Moreover, our study ROC curve analysis showed a discriminatory capability for serum CHIT1 activity in distinguishing IPF from controls using a cut-off value of 5.67 nmol/ml/h that supports serum CHIT1 potential as a diagnostic biomarker in IPF. This evidence concerns the gene CHIT1 and idiopathic pulmonary fibrosis.